Early research (Phase 1)Looking for participantsNCT07460765
What this trial is testing
Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)
Who this might be right for
HnsccHead and NeckSquamous Cell Cancer+8 more
Vanderbilt-Ingram Cancer Center 40